May 11, 2021
The maker of a potential rival to AbbVie Inc.'s blockbuster immunosuppressant Humira sued AbbVie in Virginia federal court on Tuesday, saying it wants to dismantle a long-running monopoly over a treatment protected for years by AbbVie's "minefield" of "highly-dubious patents."